NDC product
Mucinex Sinus Max Clear and Cool Severe Congestion
NDC 72854-218 · Reckitt Benckiser LLC
Key facts
| Product NDC | 72854-218 |
|---|---|
| Proprietary name | Mucinex Sinus Max Clear and Cool Severe Congestion |
| Nonproprietary name | Oxymetazoline HCI |
| Substances | OXYMETAZOLINE HYDROCHLORIDE |
| Dosage form | SPRAY |
| Route | NASAL |
| Labeler | Reckitt Benckiser LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC] |
| Marketing start | Jun 1, 2025 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: